Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.32 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17996795 | 0.87 | CA2 (0.41) | ALDH1A1CA2TSHRTDP1GABRA1 | |
| SCHEMBL17996995 | 0.87 | GABRA1 (0.40) | ALDH1A1CYP3A4CA2TSHRGABRA1 | |
| SCHEMBL20365814 | 0.85 | GABRA1 (0.39) | ALDH1A1CYP3A4CA2TSHRGABRA1 | |
| Hydrochloric Acid SCHEMBL16563090 | 0.85 | CA2 (0.40) | ALDH1A1CA2TSHRTDP1GABRA1 | |
| SCHEMBL17996993 | 0.79 | BCHE (0.36) | ALDH1A1CYP3A4CA2TSHRGABRA1 | |
| SCHEMBL17996799 | 0.79 | ACHE (0.36) | ALDH1A1CYP3A4CA2TSHRGABRA1 | |
| SCHEMBL17996807 | 0.79 | SLC22A2 (0.35) | ALDH1A1CA2TSHRTDP1 | |
| SCHEMBL18373526 | 0.78 | CA1 (0.40) | CYP3A4CA2TSHRGABRA1GABRB2 | |
| SCHEMBL17997008 | 0.78 | BCHE (0.38) | ALDH1A1CYP3A4CYP2C19CA2TSHR | |
| Hydrochloric Acid SCHEMBL16563083 | 0.76 | KIF11 (0.42) | ALDH1A1CA2TSHRTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230374230-A1 | CROSSLINKED GEL FORMULATION | ESSILOR INTERNATIONAL (FR) | 2023-11-23 | — | — | US | disclosed |
| US-20230374230-A1 | CROSSLINKED GEL FORMULATION | ESSILOR INTERNATIONAL (FR) | 2023-11-23 | — | — | US | disclosed |
| US-20230220274-A1 | ELECTROCHROMIC SOLUTION | ESSILOR INTERNATIONAL (FR) | 2023-07-13 | — | — | US | disclosed |
| US-20230220274-A1 | ELECTROCHROMIC SOLUTION | ESSILOR INTERNATIONAL (FR) | 2023-07-13 | — | — | US | disclosed |
| US-9841652-B2 | Electrochromic composition | ESSILOR INTERNATIONAL (COMPAGNIE GENERALE D'OPTIQUE) (FR) | 2017-12-12 | — | — | US | disclosed |
| US-9841652-B2 | Electrochromic composition | ESSILOR INTERNATIONAL (COMPAGNIE GENERALE D'OPTIQUE) (FR) | 2017-12-12 | — | — | US | disclosed |
| US-9785030-B2 | Electrochromic composition | ESSILOR INTERNATIONAL (COMPAGNIE GENERALE D'OPTIQUE) (FR) | 2017-10-10 | — | — | US | disclosed |
| US-9785030-B2 | Electrochromic composition | ESSILOR INTERNATIONAL (COMPAGNIE GENERALE D'OPTIQUE) (FR) | 2017-10-10 | — | — | US | disclosed |
| US-20160282694-A1 | ELECTROCHROMIC COMPOSITION | ESSILOR INTERNATIONAL (COMPAGNIE GENERALE D'OPTIQUE) (FR) | 2016-09-29 | — | — | US | disclosed |
| US-20160231636-A1 | ELECTROCHROMIC COMPOSITION | ESSILOR INTERNATIONAL (COMPAGNIE GENERALE D'OPTIQUE) (FR) | 2016-08-11 | — | — | US | disclosed |
| US-20160231636-A1 | ELECTROCHROMIC COMPOSITION | ESSILOR INTERNATIONAL (COMPAGNIE GENERALE D'OPTIQUE) (FR) | 2016-08-11 | — | — | US | disclosed |